Prudential plc (PRU.L) — Company Research
Last Updated: 11 June 2026
Prudential plc is a London- and Hong Kong-listed life and health insurer and asset manager focused entirely on Asia and Africa. The group sells protection, savings and retirement products across Greater China, ASEAN, India and Africa, and runs the Eastspring asset management business with $277.7 billion of funds under management. Its 2025 full year results, published on 18 March 2026, delivered double-digit growth across the company’s key metrics and an enlarged capital-return programme. This report sets out the facts an investor needs: how Prudential makes money, its financial track record under IFRS 17, raw valuation metrics, peers, insider activity and the key risks and dates ahead. You can follow the live price on our Live Charts page.
1. Company Snapshot
| Field | Value |
|---|---|
| Company | Prudential plc |
| Ticker / Listings | LSE: PRU (primary), HKEX: 2378 (primary), SGX: K6S, NYSE: PUK (ADR) |
| Sector | Life & health insurance and asset management (Asia and Africa) |
| Market cap | ≈£23.2bn / ≈$30.8bn (June 2026) |
| Revenue (FY2025, IFRS) | $27,755m (insurance revenue $11,080m + investment return $16,264m + other revenue $411m) |
| Net income (FY2025, IFRS) | $4,119m profit after tax ($3,978m attributable to shareholders) |
| Adjusted operating profit (FY2025) | $3,306m before tax, up 5% on a constant exchange rate basis |
| CEO / Leadership | Anil Wadhwani, Chief Executive Officer (since February 2023) |
| Employees | ≈15,300 (company data, 2026) |
| Headquarters | London, UK (registered office); principal place of business Hong Kong |
| Founded | 1848 |
| Financial year end | 31 December |
2. Bull & Bear Case
Bull Case
- Structural Asia and Africa demand: Prudential is a pure play on rising protection, retirement and wealth needs across Greater China, ASEAN, India and Africa, with top-three insurance positions in seven Asian and two African markets and growth delivered through all four quarters of 2025.
- Delivery against 2027 objectives: 2025 guidance was met in full — new business profit up 12% to $2,782m, adjusted operating EPS up 12% to 101.4 cents and operating free surplus generation up 15% to $3,059m — keeping the group on track for its 15–20% new business profit CAGR (2022–2027) and at least $4.4bn of operating free surplus generation in 2027.
- Enhanced capital returns: management expects to return more than $7bn to shareholders over 2024–2027; a $2bn buyback completed in 2025, a further $1.2bn buyback is running through 2026 and a $1.3bn capital return is expected in 2027, on top of a 2025 dividend up 15% to 26.60 cents.
- Balance sheet strength: S&P upgraded the financial strength rating of Prudential’s core entities to AA in March 2026; the GWS shareholder cover ratio stood at 262% and the free surplus ratio at 221% at end-2025, with modest group leverage of 13% (Moody’s basis).
- Momentum into 2026: the Q1 2026 update (29 April 2026) showed new business profit up a further 10% to $686m with growth in every segment and double-digit gains in Hong Kong, Mainland China and Malaysia.
Bear Case
- Hong Kong and Greater China concentration: Hong Kong alone generated $12,988m of FY2025 total revenue (≈47% of the group total) and $1,219m of segment profit, so any deterioration in Mainland Chinese visitor flows, Hong Kong market conditions or China’s economy would hit the group disproportionately.
- IFRS earnings volatility: reported profit swings with markets — the group recorded a $997m IFRS loss in 2022 and only $182m of first-half profit in 2024 before 2025’s $4,119m profit, which itself included a one-off $1,515m gain from corporate transactions (largely the ICICI Prudential AMC IPO).
- Regulatory and geopolitical exposure: the group is supervised by the Hong Kong Insurance Authority and operates across markets with shifting rules — heightened supervision of Malaysian medical insurance repricing, Indonesia’s OJK roadmap and new capital standards in Taiwan all feature in management’s own risk disclosures, alongside US–China and broader geopolitical tension.
- Asset management softness: Eastspring’s funds under management fell from $277.7bn at end-2025 to $268.9bn at 31 March 2026 on adverse market and FX movements, and asset management remains a small profit contributor ($329m of FY2025 segment profit).
- Currency mismatch: results are reported in US dollars while earnings arise in Asian and African currencies, so a strong dollar mechanically deflates reported growth.
3. Business Segments
Prudential manages the business by market, with the Eastspring asset management arm reported as its own segment. The split below uses FY2025 IFRS total revenue of $27,755m (insurance revenue plus investment return plus other revenue, after eliminations and central items of –$241m).
| Segment | % of revenue | What it is |
|---|---|---|
| Hong Kong | ≈47% ($12,988m) | The group’s largest business: life, health and savings policies sold to Hong Kong residents and Mainland Chinese visitors through agency and bancassurance; FY2025 segment profit $1,219m, up 14%. |
| Singapore | ≈26% ($7,281m) | Mature, profitable life and health franchise and a regional wealth hub; FY2025 segment profit $706m. |
| Growth markets and other | ≈13% ($3,521m) | Vietnam, Thailand, Philippines, Taiwan, India (26% stake in ICICI Prudential Life), Africa and other markets; includes the Mainland China JV (CITIC Prudential Life, FY2025 profit $411m reported separately within segment results). |
| Malaysia | ≈8% ($2,089m) | Conventional life and takaful businesses; stake in the conventional business increased to 70% in early 2026; FY2025 segment profit $410m, up 21%. |
| Indonesia | ≈5% ($1,521m) | Market-leading life and sharia insurer; FY2025 segment profit $250m amid a tougher regulatory backdrop. |
| Eastspring (asset management) | ≈2% ($596m) | Asia-based asset manager with $277.7bn of funds under management/advice at end-2025; earns management fees from in-house insurance assets and third-party clients; FY2025 segment profit $329m. |
4. Business Model & Moat
How it makes money. Prudential collects regular premiums on long-duration life and health policies and invests the float until claims fall due. Under IFRS 17 the profit emerges over the life of each policy as the contractual service margin is released, supplemented by investment returns on shareholder assets and fee income from Eastspring. New business is measured by APE sales ($6,661m in 2025, up 6%) and the value it creates by new business profit ($2,782m on a traditional embedded value basis). Cash emerges as operating free surplus from the in-force book ($3,059m in 2025), which funds new business strain, the dividend and buybacks.
The moat. A 178-year-old brand, top-three market positions in nine markets, and a multi-channel distribution machine that competitors cannot quickly replicate: a professionalised tied-agency force and exclusive bancassurance partnerships (including Standard Chartered and UOB) across Asia and Africa. Licences in markets such as Mainland China (via the CITIC Prudential JV) and India (via ICICI Prudential) are scarce assets. Scale in health and protection gives pricing and claims data advantages, and Eastspring adds vertically integrated asset management with top-ten positions in six of its markets.
Capital framework. The group runs a disciplined capital allocation model: free surplus above a 175–200% operating range is returned to shareholders, which underpins the $7bn+ 2024–2027 capital-return expectation and the growing dividend (target of growing dividend per share broadly in line with operating free surplus generation).
5. Financial Health
Figures below are from Prudential’s IFRS consolidated financial statements and full year financial supplements (all in US dollars; IFRS 17 basis from 2022 onwards). Total revenue is the sum of insurance revenue, investment return and other revenue as presented in note B1.4 of the accounts. 2022 comparatives reflect the IFRS 17 restatement.
| Year | Revenue ($m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| FY2022 | n/m (negative investment return of –$29,380m in a year of sharply rising rates) | n/m | (36.8)¢ | 79.4¢ | 18.78¢ | $4,261m |
| FY2023 | $19,503m | n/m | 62.1¢ | 89.0¢ | 20.47¢ | $3,933m |
| FY2024 | $16,659m | -14.6% | 84.1¢ | 89.7¢ | 23.13¢ | $3,925m |
| FY2025 | $27,755m | +66.6% | 154.2¢ | 101.4¢ | 26.60¢ | $4,459m |
Reported IFRS revenue swings with mark-to-market investment returns (most of which are matched by policyholder liability movements), so the steadier indicators are adjusted operating profit ($2,722m in 2022, $2,893m in 2023, $3,129m in 2024 and $3,306m in 2025) and adjusted operating EPS, which has compounded from 79.4 cents to 101.4 cents over the same period. Long-term debt is the group’s core structural borrowings of shareholder-financed businesses. Net cash flows from operating activities were $2,450m in 2025 (2024: $3,609m); cash and cash equivalents ended 2025 at $7,706m, and IFRS shareholders’ equity rose 15% to $20,117m.
Prudential reports half-yearly. The split of FY2025 is shown below (H2 derived as full year minus H1).
| Quarter / Half | Revenue ($m) | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| H2 2025 (Jul–Dec) | $15,181m | 52.1¢ | 105.0¢ |
| H1 2025 (Jan–Jun) | $12,574m | 49.3¢ | 49.2¢ |
| Full year (FY2025) | $27,755m | 101.4¢ | 154.2¢ |
6. Valuation Metrics
Raw metrics, June 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | ≈£23.2bn / ≈$30.8bn (June 2026, share price ≈926p, ≈2,500m shares) |
| Trailing P/E (GAAP) | ≈8.1x (926p ≈ $12.55 at ≈$1.355/£ ÷ FY2025 GAAP EPS of 154.2¢; note FY2025 GAAP profit included a $1,515m one-off corporate-transaction gain) |
| P/E (forward) | ≈12.4x on FY2025 adjusted operating EPS of 101.4¢ before 2026 growth — management guides double-digit growth in EPS in 2026; no analyst consensus estimates are used in this research |
| P/S (TTM) | ≈1.1x ($30.8bn market cap / $27,755m FY2025 IFRS total revenue) |
| EV/EBITDA (TTM) | n/m — EBITDA is not a meaningful measure for a life insurer under IFRS 17 (no conventional operating cost/D&A structure); the closest analogue is market cap / adjusted operating profit before tax of $3,306m ≈ 9.3x |
| P/FCF | n/m on a conventional basis — insurer cash flow is dominated by policyholder flows; market cap / IFRS operating cash flow of $2,450m ≈ 12.6x, and market cap / operating free surplus generated of $3,059m ≈ 10.1x (FY2025 cash flow statement and free surplus disclosures) |
| Enterprise value | ≈$35.3bn (market cap ≈$30.8bn + core structural borrowings of $4,459m per the FY2025 balance sheet; the $7,706m of cash and equivalents largely backs policyholder funds and is not netted off) |
| 52-week high | 1,238p |
| 52-week low | 838p |
| Short interest (% of float) | ≈0% disclosed — no current FCA-disclosable net short positions (≥0.5%) in the FCA daily register at 10 June 2026; the last disclosed position (D. E. Shaw, 0.49%) dropped below the threshold on 27 March 2026 |
| Days to cover | — not published for LSE-listed shares; UK short data is position-based via the FCA register rather than exchange-reported short interest |
7. Growth Drivers
Health and protection gap. Out-of-pocket medical spending across Asia remains among the highest in the world, and insurance penetration in markets such as Indonesia, Vietnam, the Philippines and India is a fraction of developed-market levels. Prudential is extending standalone health products and repricing medical books to capture this structurally growing demand.
Agency and bancassurance productivity. The strategy launched in 2023 focuses on professionalising the agency force (quality recruitment, digital tools, higher activation) and deepening bank partnerships, including training programmes with partners such as SCB in Thailand. Q1 2026 showed margin expansion in Hong Kong across both channels.
India and China optionality. The 26% stake in ICICI Prudential Life and the listed ICICI Prudential Asset Management stake (post-IPO), plus the CITIC Prudential JV in Mainland China, give exposure to two of the largest long-term savings pools in the world.
Capital returns as a compounding lever. The 2026 buyback of $1.2bn (about 4% of the market cap at current prices) and the expected $1.3bn return in 2027 reduce the share count while the business grows, mechanically lifting per-share metrics — weighted average shares already fell from 2,715m in 2024 to 2,580m in 2025.
8. Peer Comparison
Prudential’s closest pure-Asia comparator is AIA; the Canadian groups Manulife and Sun Life have large Asian franchises alongside North American businesses.
| Peer | Market cap (June 2026) | Key 2025 metric |
|---|---|---|
| AIA Group (HKEX: 1299) | ≈HK$744bn (≈$95bn) | Value of new business up 15% to $5,516m in FY2025; new $1.7bn buyback announced March 2026 |
| Manulife Financial (TSX/NYSE: MFC) | ≈$65bn | FY2025 core earnings of C$7.5bn, up 3% on a constant-currency basis; core EPS C$4.21, up 8% |
| Sun Life Financial (TSX/NYSE: SLF) | ≈$42bn | FY2025 underlying net income of C$4.2bn, up 9%, with underlying EPS up 12% |
9. Insider Activity
Recent PDMR (director) dealings disclosed via RNS in 2026 are dominated by incentive-plan vesting and awards to CEO Anil Wadhwani; there have been no material open-market sales disclosed by the Chief Executive in recent months.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| Anil Wadhwani (CEO) | 03 Jun 2026 | Award | 419,318 | HK$113.13 (reference) | ≈HK$47.4m (notional) | LTIP award, vesting June 2029 subject to performance |
| Anil Wadhwani (CEO) | 01 Jun 2026 | Acquisition (vesting) | 256,093 + 426 | nil consideration | — (vested shares) | LTIP vesting / deferred AIP dividend shares |
| Anil Wadhwani (CEO) | 20 May 2026 | Buy | 1 | HK$115.89 | HK$116 | Dividend reinvestment |
| Anil Wadhwani (CEO) | 15 May 2026 | Acquisition | 3,406 | HK$121.20 | ≈HK$0.41m | Annual Incentive Plan shares |
10. Key Risks
- Greater China macro and geopolitical risk: Hong Kong is roughly half of group revenue and the largest profit pool; a Chinese economic downturn, fewer Mainland visitor sales or escalation in US–China tension would directly hit new business and asset values.
- Market and interest-rate volatility: IFRS results, solvency cover (GWS ratio 262% at end-2025, down 18ppts year on year) and Eastspring FUM all move with equity and bond markets, as the Q1 2026 FUM decline showed.
- Regulatory tightening: Prudential is an Internationally Active Insurance Group supervised by the Hong Kong IA; live regulatory themes include Malaysian medical-insurance repricing supervision, Indonesia’s OJK roadmap, Taiwan’s new Insurance Capital Standard (from January 2026) and evolving rules in Vietnam, Thailand and the Philippines.
- Currency translation: earnings arise in HKD, SGD, MYR, IDR, INR and other currencies but are reported in USD; adverse FX shaved growth rates in 2025 (5% CER vs 6% AER adjusted operating profit growth).
- Competitive intensity: AIA, Manulife, Sun Life, FWD and strong local players compete for agents, bank partnerships and customers in every key market, pressuring margins and distribution costs.
- Execution and transformation risk: the strategy depends on multi-year technology modernisation, agency professionalisation and health-business build-out; management’s own disclosures flag the risk that transformation projects fail to deliver on time.
- Catastrophe, health and climate shocks: pandemics, natural catastrophes and climate transition effects could raise claims and impair investment assets.
11. Recent Developments
- 09 Jun 2026 — 2026 buyback continues. Prudential repurchased a further 418,725 shares for cancellation at prices between £9.19 and £9.67, part of the $1.2bn programme launched in January 2026; roughly 20 million shares ($312m) had already been bought back in Q1 2026.
- 03 Jun 2026 — CEO receives 419,318-share LTIP award. Anil Wadhwani was granted a Long Term Incentive Plan award at a reference price of HK$113.13, releasable in June 2029 subject to performance conditions, following the vesting of 256,093 shares on 1 June.
- 29 Apr 2026 — Q1 2026 business update: new business profit up 10%. New business profit rose 10% at constant FX to $686m with growth in every segment; APE sales rose 6% to $1,823m and new business margin improved 2ppts to 38%. Eastspring FUM eased to $268.9bn on market volatility.
- 18 Mar 2026 — FY2025 results: double-digit growth and bigger capital returns. New business profit up 12% to $2,782m, adjusted operating EPS up 12% to 101.4¢, dividend up 15% to 26.60¢, a new $1.2bn buyback for 2026 and an expected $1.3bn capital return in 2027; S&P upgraded core entities to AA. The group also raised its Malaysian conventional business stake to 70% in early 2026.
12. Key Dates
- Expected Aug 2026 — Half-year 2026 results (the 2025 half-year results were released on 27 August 2025; date to be confirmed on the company’s financial calendar)
- Expected Oct 2026 — Q3 2026 business performance update
- Expected Dec 2026 — completion of the $1.2bn 2026 share buyback programme (running through the course of 2026)
- Expected 2027 — $1.3bn capital return comprising recurring returns and ICICI Prudential AMC IPO net proceeds
Macro events that move insurers — Fed and BoE rate decisions, China data releases — can be tracked on our Economic Calendar, and you can discuss Prudential with other investors on the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Loading research report…
13. Thesis Verdict
The central thesis. Prudential plc sells life and health insurance and asset management across Greater China, ASEAN, India and Africa, earning long-duration premium income, investment returns and Eastspring fee income from $277.7bn of funds under management. FY2025 delivered double-digit growth across its key metrics: new business profit up 12% to $2,782m, adjusted operating EPS up 12% to 101.4 cents, IFRS profit of $4,119m and a dividend up 15% to 26.60 cents, with management guiding further double-digit growth in 2026 and confirming its 2027 objectives of 15–20% new business profit CAGR and at least $4.4bn of operating free surplus generation. The primary near-term drivers are Asian health-and-protection demand, agency and bancassurance productivity, and a capital-return programme expected to exceed $7bn over 2024–2027, including a $1.2bn buyback running through 2026.
What would confirm or break it. Confirmation would come from half-year 2026 results extending the Q1 momentum (new business profit up 10%) and continued delivery against the 2027 objectives alongside the buyback. The thesis would weaken if Hong Kong — roughly 47% of revenue — stumbled on Chinese macro or visitor flows, if market volatility eroded the GWS cover ratio (262%) or Eastspring FUM further, or if regulatory tightening in Malaysia, Indonesia or Mainland China constrained growth and margins.
Watchpoints
- ConfirmsHalf-year 2026 results (expected late August 2026) (77 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "Structural Asia and Africa demand:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "Greater China macro and geopolitical risk:" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 11 Jun 2026.
